Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer: Stage 1 of a Simon 2 Stage Clinical Trial. [Corrected]
评估舒尼替尼、多西他赛（Tyxan）和顺铂挽救治疗后序贯长春瑞滨维持治疗对不可切除/转移性非小细胞肺癌的安全性和有效性：Simon 2期临床试验的第一阶段。[已更正]
期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000002303
Tai, Cheng-Jeng; Wang, Chien-Kai; Tai, Chen-Jei; Tzao, Ching; Lien, Yung-Chang; Hsieh, Chih-Cheng; Hsieh, Cheng-I; Wu, Hong-Cheng; Wu, Chih-Hsiung; Chang, Chun-Chao; Chen, Ray-Jade; Chiou, Hung-Yi
